300247.SZ
融捷健康
SZSE · Consumer Cyclical · C 制造业 · CN
CNY 3.67
−0.54%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 921.4M | 933.2M | 688.8M | 529.4M | 463.3M |
| Cost of Revenue | 584.2M | 595.7M | 469.7M | 355.5M | 352.0M |
| Gross Profit | 337.2M | 337.4M | 219.1M | 174.0M | 111.3M |
| Operating Expenses | |||||
| R&D Expense | 12.4M | 12.3M | 11.7M | 9.1M | 11.0M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 85.5M | 84.6M | 64.8M | 58.0M | 49.5M |
| Selling & Marketing Expense | 92.3M | 91.5M | 70.3M | 61.5M | 55.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 196.6M | 189.3M | 135.9M | 125.6M | 111.5M |
| Cost and Expenses | 780.8M | 785.1M | 605.6M | 481.0M | 463.5M |
| Operating Income (EBIT) | 139.3M | 145.4M | 88.1M | 59.4M | 137.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 141.1M | 147.9M | 88.2M | 59.8M | 136.4M |
| Income Tax Expense | 39.6M | 39.8M | 22.1M | 17.8M | 3.1M |
| Bottom Line | |||||
| Net Income | 67.6M | 74.8M | 46.9M | 26.6M | 126.3M |
| Earnings from Cont. Ops | 101.5M | 108.1M | 66.1M | 41.9M | 133.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 67.6M | 74.8M | 46.9M | 26.6M | 126.3M |
| Per Share | |||||
| Basic EPS | CN¥0.08 | CN¥0.09 | CN¥0.06 | CN¥0.03 | CN¥0.16 |
| Diluted EPS | CN¥0.08 | CN¥0.09 | CN¥0.06 | CN¥0.03 | CN¥0.16 |
| Revenue Per Share | CN¥1.15 | CN¥1.12 | CN¥0.88 | CN¥0.60 | CN¥0.59 |
| Shares | |||||
| Basic Shares Outstanding | 804.6M | 831.1M | 780.9M | 886.1M | 789.4M |
| Diluted Shares Outstanding | 804.6M | 831.1M | 780.9M | 886.1M | 789.4M |
| Profitability Metrics | |||||
| EBITDA | — | 161.7M | 104.7M | 76.9M | 155.6M |
| D&A | — | 16.3M | 16.5M | 17.5M | 18.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026